Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...
In a new study, 18- to 21-year-olds exposed to a diet high in ultra-processed foods were more likely to overeat—even when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback